Table 4.
Symptoms scores in antibody-positive and negative schizophrenia subjects.
| AGA positive (mean ± SD) N = 9 | AGA negative (mean ± SD) N = 90a | T | Df | p value | |
|---|---|---|---|---|---|
| Calgary Depression Rating Scale | 1.22 ± 1.48 | 1.84 ± 2.23 | 0.58 | 1 | 0.447 |
| BPRS total score | 28.56 ± 3.09 | 32.15 ± 6.84 | 2.40 | 1 | 0.121 |
| BPRS positive symptoms | 4.11 ± 1.36 | 6.39 ± 2.99 | 5.38 | 1 | 0.020 |
| BPRS negative symptoms | 6.56 ± 2.51 | 6.71 ± 2.61 | 0.01 | 1 | 0.922 |
| BPRS hostility | 4.11 ± 1.17 | 4.52 ± 1.75 | 0.20 | 1 | 0.651 |
| BPRS anxiety/depression | 5.33 ± 1.80 | 6.00 ± 2.47 | 0.46 | 1 | 0.499 |
| BPRS agitation | 4.11 ± 1.27 | 3.94 ± 1.38 | 0.30 | 1 | 0.586 |
| RBANS total score | 71.89 ± 17.30 | 73.62 ± 16.60 | 0.10 | 1 | 0.755 |
| Acid Relux/GERDb | 1 (11%) | 11 (12%) | |||
| Constipation | 0 | 4 (4%) | |||
| Types I or II diabetes | 1 (11%) | 16 (18%) |
a
Excludes the tTG- and EMA-positive, but AGA negative participant.
b
Gastrointestinal reflux/GERD (gastroesophageal reflux disease) and constipation were the only gastrointestinal symptoms noted on the medical examination. One person had Crohn’s disease in the AGA negative schizophrenia group.